HOME > EDUCATION > RESOURCES & TOOLS > AIM > AIM: Rheumatoid Arthritis Practice Improvement Module Development Group

AIM: Rheumatoid Arthritis Practice Improvement Module Development Group

AIM: Rheumatoid Arthritis Practice Improvement Module Development Group

Audrey B. Uknis, MD, Chair
Temple University School of Medicine
Philadelphia, PA

Alan L. Epstein, MD
Pennsylvania Hospital, Rheumatology
Philadelphia, PA

Alan K. Matsumoto, MD
Arthritis & Rheumatism Association
Wheaton, MD

Stuart J. Schneller, MD
Boston, MA

John RP Tesser, MD
AZ Arthritis Rheum Assoc
Paradise Valley, AZ

Conflict of Interest / Disclosure Statements

As an educational provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) it is the ACR’s policy to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
  7. Receipt of royalties
  8. Speakers’ bureau
  9. Other

Faculty disclosures listed apply in numeric format according to the list above. In accordance with ACR policy an individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for the development, management, presentation or evaluation of the CME activity.

The faculty reported the following disclosures:

  • Audrey B. Uknis, MD, Chair – Biogen-Idec, Roche: 2, 5
  • Alan L. Epstein, MD - Abbott Immunology, Eli Lilly, Genentech, Ortho McNeil, Pfizer: 8.
  • Alan K. Matsumoto, MD – Abbott, Centocor, Endo, Genentech, Glaxo Smith Kline, Merck, Novartis, Roche: 2; Abbott: 8.
  • Stuart J. Schneller, MD – Nothing to disclose
  • John RP Tesser, MD – Alexion, Amgen, Genentech, Wyeth: 5; Amgen, Bristol-Myers Squibb, Genentech, Glaxo Smith Kline, Lilly, Merck, Roche, Wyeth: 8.